Evidence map›Paper›PMID 29463756›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Diagnostic utility of telomere length testing in a hospital-based setting.

Jonathan K Alder, Vidya Sagar Hanumanthu, Margaret A Strong, Amy E DeZern, Susan E Stanley, Clifford M Takemoto, Ludmila Danilova, Carolyn D Applegate, Stephen G Bolton, David W Mohr and 5 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 151 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 3 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 3 syntheses or guidelines pooled it, 272 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jonathan K AlderDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Vidya Sagar HanumanthuDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Margaret A StrongTelomere Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Amy E DeZernDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Susan E StanleyDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Clifford M TakemotoDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Ludmila DanilovaDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Carolyn D ApplegateDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Stephen G BoltonDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
David W MohrMcKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Robert A BrodskyDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
James F CasellaDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Carol W GreiderDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287; cgreider@jhmi.edu marmani1@jhmi.edu.
J Brooks JacksonDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Mary ArmaniosDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287; cgreider@jhmi.edu marmani1@jhmi.edu.ORCID 0000-0002-7105-1847
Johns Hopkins University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007309 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 1985 to 2019
$43.2M
STRUCTURE/FUNCTION OF TELOMERES IN MAMMALIAN AGINGR37AG009383 · NIA · JOHNS HOPKINS UNIVERSITY · PI GREIDER, CAROL W · 1997 to 2016
$6.1M
Mechanisms of Telomere-Induced EmphysemaR01HL119476 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ARMANIOS, MARY Y · 2014 to 2023
$4.5M
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)R01CA160433 · NCI · JOHNS HOPKINS UNIVERSITY · PI ARMANIOS, MARY Y · 2012 to 2016
$1.7M
Mechanisms of Teleomere-Mediated EmphysemaR00HL113105 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALDER, JONATHAN K. · 2014 to 2016
$743k
Advancing Diagnostics and Therapeutics in Bone Marrow FailureK23HL123601 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DEZERN, AMY E · 2014 to 2017
$637k
NCI NIH HHS R01 CA160433NHLBI NIH HHS K23 HL123601NHLBI NIH HHS R00 HL113105NHLBI NIH HHS R01 HL119476NIA NIH HHS R37 AG009383NIGMS NIH HHS T32 GM007309
6 · The paper itself

Abstract

Telomere length (TL) predicts the onset of cellular senescence in vitro but the diagnostic utility of TL measurement in clinical settings is not fully known. We tested the value of TL measurement by flow cytometry and FISH (flowFISH) in patients with mutations in telomerase and telomere maintenance genes. TL had a discrete and reproducible normal range with definable upper and lower boundaries. While TL above the 50th age-adjusted percentile had a 100% negative predictive value for clinically relevant mutations, the lower threshold in mutation carriers was age-dependent, and adult mutation carriers often overlapped with the lowest decile of controls. The extent of telomere shortening correlated with the age at diagnosis as well as the short telomere syndrome phenotype. Extremely short TL caused bone marrow failure and immunodeficiency in children and young adults, while milder defects manifested as pulmonary fibrosis-emphysema in adults. We prospectively examined whether TL altered treatment decisions for newly diagnosed idiopathic bone marrow failure patients and found abnormally short TL enriched for patients with mutations in some inherited bone marrow failure genes, such as

Indexed as

Telomere ShorteningAdolescentAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolFemaleHospitalsHumansInfantIn Situ Hybridization, FluorescenceMaleMiddle AgedMutationTelomeraseaplastic anemiainterstitial lung diseaseliver diseaseprecision medicineprimary immunodeficiency

Identifiers

PMID29463756
PMCPMC5877993
OpenAlexW2793592971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.